Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,527 across all filing types
Latest filing 2012-03-20 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
Date of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a short announcement from China Pharmaceutical Group Limited stating the date of a board meeting to approve final results for the year ended 31 December 2011 and to consider a final dividend. It does not contain any financial data or detailed report content but merely announces the upcoming board meeting and its agenda. The document length is only 1356 characters, which is very short and fits the pattern of an announcement rather than a full report. According to the rules, such short announcements about meetings to approve results and dividends are classified as Regulatory Filings (RNS) because they do not contain the actual report or financial statements but are regulatory announcements about corporate events.
2012-03-20 English
Monthly return of equity issuer on movements in securities for the month ended 29 February 2012
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 29/2/2012, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital/financing update. The document is substantive and not a brief announcement or certification. Therefore, it fits best under Capital/Financing Update (CAP).
2012-03-02 English
Monthly return of equity issuer on movements in securities for the month ended 31 January 2012
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/1/2012, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange rules. This fits the category of Capital/Financing Update (CAP) as it provides updates on company fundraising, financing activities, or capital structure changes.
2012-02-01 English
Appointment of Executive Director
Board/Management Information Classification · 100% confidence The document is an announcement from the Board of Directors regarding the appointment of an executive director, Mr. Wang Zhenguo. It details his background, terms of appointment, remuneration, and confirms compliance with disclosure rules under the Hong Kong Stock Exchange listing requirements. There is no financial data, no report or presentation, and no mention of voting results or other categories. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2012-01-20 English
Monthly return of equity issuer on movements in securities for the month ended 31 December 2011
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2011, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital/financing update or share capital change report. Given the detailed monthly movements in share capital and securities, the document best fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement but a substantive report on share capital changes.
2012-01-03 English
Monthly return of equity issuer on movements in securities for the month ended 30 November 2011
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2011, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and related securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital/financing update. The document length is about 14,416 characters, containing detailed tables and data on share capital changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2011-12-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.